quantisnow
FeedTopReportsPricing
⌘K
Live feed
04:34:46·968d
FDARegulatory
Celgene Corporation logo

FDA Approval for REBLOZYL issued to CELGENE CORP

CELG~· Celgene Corporation
Original source

Companies

  • CELG~
    Celgene Corporation
    n/a

Related

  • FDA706d
    FDA Approval for REBLOZYL issued to CELGENE CORP
  • FDA1382d
    FDA Approval for REBLOZYL issued to CELGENE CORP
  • FDA1731d
    FDA Approval for IDHIFA issued to CELGENE CORP
  • FDA1853d
    March 27, 2021 - FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
  • PR1969d
    Sutro Biopharma Announces Appointment of Jon M. Wigginton, M.D., to Board of Directors
  • PR1976d
    Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer
  • PR1977d
    Global Stem Cells Market is estimated to account for US$ 18,289.9 Mn by end of 2027, Says Coherent Market Insights (CMI)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022